Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.25M Sell
23,872
-721
-3% -$38.1K 0.08% 255
2026
Q1
$1.36M Sell
24,593
-6,259
-20% -$339K 0.1% 214
2025
Q4
$1.51M Sell
30,852
-4,442
-13% -$207K 0.11% 197
2025
Q3
$1.52M Sell
35,294
-576
-2% -$22.5K 0.12% 196
2025
Q2
$1.38M Buy
35,870
+1,186
+3% +$45.3K 0.11% 213
2025
Q1
$1.34M Buy
34,684
+34,652
+108,288% +$1.27M 0.11% 196
2024
Q4
$1.1K Sell
32
-32,429
-100% -$1.17M 0.1% 218
2024
Q3
$1.33M Sell
32,461
-471
-1% -$19.3K 0.11% 192
2024
Q2
$1.27M Sell
32,932
-403
-1% -$17K 0.12% 189
2024
Q1
$1.43M Sell
33,335
-562
-2% -$23.2K 0.13% 158
2023
Q4
$1.26M Sell
33,897
-2,575
-7% -$92.4K 0.13% 162
2023
Q3
$1.32M Buy
+36,472
New +$1.29M 0.15% 139

Other funds holding GSK

NBC Securities's GSK Position: Q2 2026 in Review

NBC Securities reduced its GSK (GSK) stake by 2.9% in Q2 2026, selling an estimated $38.1K and leaving 23,872 shares worth $1.25M. The position accounts for 0.08% of the portfolio, ranked #255.

NBC Securities first reported a position in GSK in Q3 2023 and has held it in 12 quarters since. The position peaked at $1.52M in Q3 2025. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • NBC Securities held 23,872 shares of GSK worth $1.25M as of Q2 2026.
  • NBC Securities sold 721 GSK shares in Q2 2026, an estimated $38.1K.
  • GSK made up 0.08% of NBC Securities's portfolio in Q2 2026, its #255 holding.
  • NBC Securities first reported a position in GSK in Q3 2023 and has held it in 12 quarters since.
  • NBC Securities's GSK position peaked at $1.52M in Q3 2025.
  • 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on NBC Securities's 13F filing for Q2 2026, filed 21 Jul 2026.